Stonepine Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
|
|||||
|
2025
Q1 | $161K | Buy |
|
|||||
|
2024
Q4 | $120K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.06M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $18.9M | Buy |
|
|||||
|
2019
Q1 | $23.2M | Buy |
|
|||||
|
2018
Q4 | $5.77M | Sell |
|
|||||
|
2018
Q3 | $7.45M | Sell |
|
|||||
|
2018
Q2 | $11.4M | Sell |
|
|||||
|
2018
Q1 | $16.6M | Buy |
|
|||||
|
2017
Q4 | $13.5M | Buy |
|
|||||
|
2017
Q3 | $5.37M | Sell |
|
|||||
|
2017
Q2 | $11.2M | Buy |
|
|||||
|
2017
Q1 | $606K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $9.08M | Sell |
|
|||||
|
2016
Q1 | $17.3M | Buy |
|
|||||
|
2015
Q4 | $17.9M | Buy |
|